Scripta MedicaPub Date : 2022-01-01DOI: 10.5937/scriptamed53-32417
Sanja Petković, S. Petković, Ljiljana Tadić-Latinović, J. Berendika, B. Tubić, S. Jungić
{"title":"A case report of malignant peripheral nerve sheath tumour of the left thigh and popliteal fossa with lungs, spleen, and brain dissemination related to neurofibromatosis type 1","authors":"Sanja Petković, S. Petković, Ljiljana Tadić-Latinović, J. Berendika, B. Tubić, S. Jungić","doi":"10.5937/scriptamed53-32417","DOIUrl":"https://doi.org/10.5937/scriptamed53-32417","url":null,"abstract":"A malignant peripheral nerve sheath tumour (MPNST) is a highly aggressive sarcoma. This disease develops in a number of people with neurofibromatosis type 1 (NF1), which is a common genetic disease. The paper presents a patient with typical manifestations of a malignant tumour of the peripheral nerve sheath, in the form of a large tumour of primary localisation in the distal part of the left thigh and left popliteal fossa and with significant dissemination into the lung parenchyma, which was accompanied by respiratory risk. The first operation of the tumour was done four years earlier, after which the patient did not come for regular check-ups. Nine cycles of chemotherapy were performed by Doxorubicin / Ifosfamide / Mesna protocol with clinical improvement and stabilisation, but without a significant impact on the dynamics of the disease and the overall survival was 14 months. It is of utmost importance to early recognise clinical presentation of the malignant form of this tumour and active supervision of a patient with a benign form by experts. In this way, it is possible to apply the optimal treatment modality in a timely manner.","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82017219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Scripta MedicaPub Date : 2022-01-01DOI: 10.5937/scriptamed53-36101
R. Igić
{"title":"Technical innovation of Ervin G Erdös: A mechanical transducer for isotonic muscle contractions","authors":"R. Igić","doi":"10.5937/scriptamed53-36101","DOIUrl":"https://doi.org/10.5937/scriptamed53-36101","url":null,"abstract":"Let me explain the principle of bioassay. It is an analytical method for determination of the relative strength (concentration or potency) of a substance by comparing its effect on a test organism (living animal, cells or tissues) with that of a standard preparation. Bioassays are used in pharmacology mainly to determine the concentrations of hormones or drugs, eg biologically active peptides, acetylcholine, catecholamines, prostaglandins, histamine and prostacyclin. However, there are other forms of bioassay in which one can use isolated tissues and determine actions of their nerves, such as the nerve to the diaphragm from rats. Bioassays may also be done in vivo in individual humans. The assessment of drug effects in humans is designated by clinical pharmacologists as a clinical trial. Such trials often require hundreds or sometimes thousands of patients in order to test efficacy and safety of any new drug before it can be marketed. If the human investigations produce unexpected results, quite different of those obtained in the animal experiments the trials must be redesigned, to examine why and how this occurred. There are many examples of how such discoveries resulted in new clinically useful medications (eg, discovery antihypertensive effect of beta-adrenergic blocking agents).6 Accordingly, the pharmacologists have the bioassays, as a tool, which help them in the discovery process. I wrote on the renowned pharmacologist Professor Ervin G Erdös and his scientific opus in my reminiscence article written on the occasion of his death in 2019.1 When I attended the Fourth International Congress in Pharmacology in Basel in 1969, Dr Ervin G Erdös invited me to join his laboratory. Thus, in April 1970, I arrived in Oklahoma City as a Fulbright Fellow to work with him for two years. Later on, as a visiting scientist I frequently worked in his research laboratories in Dallas and Chicago and we shared research interests through visits across the Atlantic between the former Yugoslavia and the United States.2, 3","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83075192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Scripta MedicaPub Date : 2022-01-01DOI: 10.5937/scriptamed53-41392
P. Nawghare, S. Nair, Shubham Jain, S. Bansal, S. Chandnani, S. Rathi, P. Rathi
{"title":"A case of COVID-19 presenting as acute liver failure","authors":"P. Nawghare, S. Nair, Shubham Jain, S. Bansal, S. Chandnani, S. Rathi, P. Rathi","doi":"10.5937/scriptamed53-41392","DOIUrl":"https://doi.org/10.5937/scriptamed53-41392","url":null,"abstract":"Although children with COVID-19 make up a small proportion of patients and have milder symptoms than adults, liver damage is a well-documented side effect of COVID-19 infection. Most liver damage caused by COVID-19 is modest. In this report, a case of a 6-year-old child who was hospitalised to a paediatric intensive care unit (PICU) with COVID-19 manifested as acute liver failure is described.","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":"245 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74703817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Scripta MedicaPub Date : 2022-01-01DOI: 10.5937/scriptamed53-36256
S. Bhullar, A. Shah, N. Dhalla
{"title":"Mechanisms for the development of heart failure and improvement of cardiac function by angiotensin-converting enzyme inhibitors","authors":"S. Bhullar, A. Shah, N. Dhalla","doi":"10.5937/scriptamed53-36256","DOIUrl":"https://doi.org/10.5937/scriptamed53-36256","url":null,"abstract":"Angiotensin-converting enzyme (ACE) inhibitors, which prevent the conversion of angiotensin I to angiotensin II, are well-known for the treatments of cardiovascular diseases, such as heart failure, hypertension and acute coronary syndrome. Several of these inhibitors including captopril, enalapril, ramipril, zofenopril and imidapril attenuate vasoconstriction, cardiac hypertrophy and adverse cardiac remodeling, improve clinical outcomes in patients with cardiac dysfunction and decrease mortality. Extensive experimental and clinical research over the past 35 years has revealed that the beneficial effects of ACE inhibitors in heart failure are associated with full or partial prevention of adverse cardiac remodeling. Since cardiac function is mainly determined by coordinated activities of different subcellular organelles, including sarcolemma, sarcoplasmic reticulum, mitochondria and myofibrils, for regulating the intracellular concentration of Ca2+ and myocardial metabolism, there is ample evidence to suggest that adverse cardiac remodelling and cardiac dysfunction in the failing heart are the consequence of subcellular defects. In fact, the improvement of cardiac function by different ACE inhibitors has been demonstrated to be related to the attenuation of abnormalities in subcellular organelles for Ca2+-handling, metabolic alterations, signal transduction defects and gene expression changes in failing cardiomyocytes. Various ACE inhibitors have also been shown to delay the progression of heart failure by reducing the formation of angiotensin II, the development of oxidative stress, the level of inflammatory cytokines and the occurrence of subcellular defects. These observations support the view that ACE inhibitors improve cardiac function in the failing heart by multiple mechanisms including the reduction of oxidative stress, myocardial inflammation and Ca2+-handling abnormalities in cardiomyocytes.","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74758410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Scripta MedicaPub Date : 2022-01-01DOI: 10.5937/scriptamed53-41336
R. Oktaviani, Iwan Dewanto
{"title":"Assessment of factors influencing the patient's perception of teledentistry services","authors":"R. Oktaviani, Iwan Dewanto","doi":"10.5937/scriptamed53-41336","DOIUrl":"https://doi.org/10.5937/scriptamed53-41336","url":null,"abstract":"Background/Aim: The trend of using teledentistry increased significantly during the pandemic. Many studies have analysed patients' perceptions of teledentistry, but no studies have examined the factors that influence these perceptions. Aim of this study was to determine the factors that influenced the patient's perception of teledentistry. Methods: This type of research was a descriptive analysis with a cross sectional design. A total of 170 respondents filled out a questionnaire containing sociodemographic data and statements with a Likert scale related to the five perceptual domains of teledentistry. The data were analysed for correlation test with SPSS and model test with SEM-PLS. Results: There were only two factors, namely age and level of education that appear as factors that affect the patient's perception with a correlation significance value of 0.001 for age and 0.005 for education. The value of the correlation coefficient was positive, which means that the higher the age and level of education, there was a greater tendency for perceived value to be more strongly agreed. These results were reinforced by the results of the coefficient values on the SEM-PLS model test which were positive and significant, namely 0.311. The results of the goodness of fit analysis in this study were in the moderate category with a value of 0.265. However, the imbalance in the number of respondents in each sociodemographic group makes the results of this study less representative. Conclusion: There was a significant positive correlation between the level of education and the perception of teledentistry. This means that the higher a person's education level, the better his perception of teledentistry. Age had a significant positive correlation and influence with the patient's perception of teledentistry.","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":"170 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77538045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Scripta MedicaPub Date : 2022-01-01DOI: 10.5937/scriptamed53-35502
B. Mijovic, Jela Aćimović, Jelena Đaković-Dević, Julija Kralj, Bojan Joksimović, Vesna Lučić-Samardžija, Mirjana Đermanović, Vesna Vujić-Aleksić, B. Zeljković, Snežana Perić-Simić
{"title":"Knowledge, attitudes and practices of parents regarding antibiotic use among children: Differences between urban and rural areas in the Republic of Srpska","authors":"B. Mijovic, Jela Aćimović, Jelena Đaković-Dević, Julija Kralj, Bojan Joksimović, Vesna Lučić-Samardžija, Mirjana Đermanović, Vesna Vujić-Aleksić, B. Zeljković, Snežana Perić-Simić","doi":"10.5937/scriptamed53-35502","DOIUrl":"https://doi.org/10.5937/scriptamed53-35502","url":null,"abstract":"Background/Aim: Antibiotic use and resistance represent a growing public health issue, with a specific risk of uncontrolled use of antibiotics in children. The aim of the study was to examine differences in parental knowledge, attitudes and practices about antibiotic use in children between urban and rural areas of the Republic of Srpska. Methods: A cross-sectional study was conducted among 1459 parents of children under 6 years of age, out of which 1201 (82.3 %) lived in urban areas while 258 (17.7 %) lived in rural areas. The research is conducted among parents who brought their children to the selected primary healthcare centres and among parents of children in preschool institutions. Results: The majority of respondents (98.4 %) state that doctors are their main source of information. Only 61.2 % of respondents precisely know which drug is an antibiotic when offered different drugs and respondents from rural areas (54.3 %) more often (p = 0.012) gave more accurate answers when compared to respondents from urban areas (37.3 %). Among parents, 86 % agree with the statement that improper use of antibiotics reduces their effectiveness and leads to bacterial resistance, regardless of groups. More than a half of respondents (52.4 %) do not think that children with flu or common cold symptoms recover faster when they receive antibiotics, significantly more respondents from urban areas (p = 0.001). Respondents from rural areas significantly more often believe that antibiotics can produce harmful effects compared to respondents from urban areas (p = 0.049). Respondents from rural areas significantly more often think that antibiotic use can prevent complications caused by inflammation of the upper respiratory tract (p = 0.006). Parents from rural areas give their children antibiotics without a paediatrician's recommendation significantly more often (4.3 %) compared to respondents from urban areas (0.6 %) (p < 0.001). Conclusion: There are differences in parental knowledge, attitudes and practices regarding antibiotic use and antimicrobial resistance among parents in rural and urban areas. There is need for additional education of parents and for greater engagement of paediatricians in providing guidance and explanations regarding the use of antibiotics.","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":"56 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81172855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Scripta MedicaPub Date : 2022-01-01DOI: 10.5937/scriptamed53-41890
Tatjana Erceg-Rukavina, Dragana Dragičević-Cvjetković, Dragana Đurić, M. Stojiljković, R. Škrbić
{"title":"The effect of sulphate-sulphide mineral baths on blood glucose level in patients with knee osteoarthritis","authors":"Tatjana Erceg-Rukavina, Dragana Dragičević-Cvjetković, Dragana Đurić, M. Stojiljković, R. Škrbić","doi":"10.5937/scriptamed53-41890","DOIUrl":"https://doi.org/10.5937/scriptamed53-41890","url":null,"abstract":"Background/Aim: Type 2 diabetes is a common comorbidity in patients with knee osteoarthritis. Bearing in mind that obesity and insulin resistance are risk factors for the development of knee osteoarthritis, physical therapy and balneotherapy containing hydrogen sulphide (H2S) has a positive effect on the functional and metabolic status of these patients. This work was aimed to investigate the effect of sulphate-sulphide-rich mineral baths containing H2S on the level of serum glucose in patients with knee osteoarthritis. Methods: An open prospective randomised clinical trial included patients suffering from stage I and II of the knee osteoarthritis. Patients were divided into two groups of 40 subjects each: control group and experimental group. All subjects underwent inpatient physical treatment consisting of kinesitherapy and transcutaneous electrical nerve stimulation (TENS) 6 days a week. Patients from experimental group, in addition to all the mentioned treatments, also took sulphate-sulphide mineral water baths once a day for 30 minutes for 7 days, unlike the patients from control group who took tap water baths, according to the same schedule. The level of serum glucose was monitored in all patients on admission, after discharge and 6 months after the treatment. The Student t-test was used for statistical data processing and p < 0.05 was considered as statistically significant. Results: Study included 80 patients of both sexes, with an average age of 67.00 ± 5.75 years. All patients had elevated serum glucose values on admission. The initial levels of glycaemia in the control and experimental groups were not significantly different (6.99 ± 1.95 and 7.88 ± 1.90 mmol/L, respectively). At discharge, patients who performed balneotherapy had a statistically significant decrease in serum glucose values compared to patients from the control group (by 1.84 vs 0.26 mmol/L, p < 0.001). This effect did not persist six months after the end of the treatment (p > 0.05). Conclusion: The application of balneotherapy with sulphate-sulphide mineral baths containing H2S as a potent gas transmitter significantly reduces serum glucose levels in patients with knee osteoarthritis.","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87739546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Scripta MedicaPub Date : 2022-01-01DOI: 10.5937/scriptamed53-36048
Vesna Gajanin, Nikola Baroš, G. Marošević, Đuka Ninković-Baroš, Jagoda Balaban
{"title":"New approaches in management and treatment of 'Hidradenitis suppurativa'","authors":"Vesna Gajanin, Nikola Baroš, G. Marošević, Đuka Ninković-Baroš, Jagoda Balaban","doi":"10.5937/scriptamed53-36048","DOIUrl":"https://doi.org/10.5937/scriptamed53-36048","url":null,"abstract":"Background / Aim: Hidradenitis suppurativa (HS) is a chronic inflammatory disease that most often affects apocrine gland-bearing areas of the skin. The treatment depends on the severity of the clinical presentation. The paper objective was to present new modalities in management and treatment of HS. Methods: The subjects in this research included the patients suffering from the severe form of HS, who were treated in the University Clinical Centre of the Republic of Srpska for the past three years. The effect of treatment of HS were monitored. In four patients, biologic therapy with adalimumab or adalimumab biosimilars was administered, while four patients received radiotherapy and 17 of them, were treated surgically. Depending on the type of treatment, the effects of therapy were monitored after 6-12 weeks by using clinical examination and by assessing the disease stage according to the Hurley staging. Due to a small number of subjects, especially in patients treated with biologic and radiotherapy, it was not possible to perform any statistical analysis and the results were presented by description, in tables and photographs. Results: Biologic therapy: Adalimumab was administered subcutaneously 80 mg, twice a month. After 12 weeks, in 4 patients was observed a regression of changes by 60-70 % when compared to previous skin changes. Radiotherapy: the total radiation dose was 5 Gy, distributed in 5 or 10 fractions. After 12 weeks an improvement by 60-70 % was observed. Surgical treatment: after 6-8 weeks, the patients were fully recovered. Conclusions: Application of biologic and radiotherapy after 12 weeks had similar results, ie it brought to regression of changes by 60-70 %. The best results were achieved after surgical treatment of HS.","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":"51 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87136167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Scripta MedicaPub Date : 2022-01-01DOI: 10.5937/scriptamed53-37135
D. Lončar-Stojiljković, Ž. Maksimović, M. Đurić
{"title":"Use of an ultrashort-acting selective β1-adrenergic receptor antagonist esmolol in ear, nose and throat surgery","authors":"D. Lončar-Stojiljković, Ž. Maksimović, M. Đurić","doi":"10.5937/scriptamed53-37135","DOIUrl":"https://doi.org/10.5937/scriptamed53-37135","url":null,"abstract":"Background / Aim: The concept of general balanced anaesthesia was devised in order to assure cardiovascular stability and fast post-anaesthesia recovery. This clinical trial was organised in order to investigate the parameters of cardiovascular function and emergence from anaesthesia in elective ear, nose and throat (ENT) surgery patients. Methods: A total of 40 ASA I and II patients of both sexes scheduled for elective ENT surgery were randomly divided into two equal groups. Both groups received a continuous IV infusion of glucose 5 % solution and in the esmolol group this infusion also contained esmolol. Esmolol infusion rate was 0.3 mg/kg/min during the first 5 min and thereafter 0.1 mg/kg/min. In critical phases of anaesthesia and operation (induction, intubation, first incision, surgical manipulations, wound suture, extubation), systolic and diastolic blood pressure were monitored. Recovery after anaesthesia was assessed based on times of eye opening on command, spontaneous eye opening and regaining of full orientation. Increases in cardiovascular parameters by 20 % of the baseline values or more were treated with IV boluses of fentanyl, alone or with droperidol and, if necessary, by adding isoflurane 0.5 % to the inhalational mixture. Consumption of drugs was recorded. Results: Esmolol assured stable values of cardiovascular parameters that were in most critical phases of anaesthesia and operation lower than in the control group. The duration of anaesthesia did not differ between the groups. In the esmolol group, lower consumption of fentanyl, droperidol and sevoflurane was registered. Patients in the esmolol group emerged from anaesthesia faster than patients in the control group. Conclusion: Continuous IV infusion of esmolol assures better cardiovascular stability, necessitates lower consumption of analgesics and anaesthetics and results in faster emergence from general anaesthesia in elective ENT surgery.","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88608110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Scripta MedicaPub Date : 2021-01-04DOI: 10.21203/rs.3.rs-39611/v2
S. Bhandari, A. Shaktawat, A. Tak, J. Shukla, J. Gupta, Bhoopendra Patel, Shivankan Kakkar, A. Dube, Sunita Dia, Mahendra Dia, T. Wehner
{"title":"Relationship Between ABO Blood group Phenotypes and nCOVID-19 Susceptibility – A Retrospective Observational Study","authors":"S. Bhandari, A. Shaktawat, A. Tak, J. Shukla, J. Gupta, Bhoopendra Patel, Shivankan Kakkar, A. Dube, Sunita Dia, Mahendra Dia, T. Wehner","doi":"10.21203/rs.3.rs-39611/v2","DOIUrl":"https://doi.org/10.21203/rs.3.rs-39611/v2","url":null,"abstract":"\u0000 Background: Since the outbreak of coronavirus disease-19 research has been continued to explore multiple facets of the disease. The objective of the present study is to evaluate the relationship between blood group phenotypes and COVID-19 susceptibility.Methods: In this hospital based, retrospective observational study 132 COVID-19 patients were enrolled from SMS Medical Hospital in Jaipur, India after receiving approval from the institutional ethics committee. The ABO, Rh and Kell blood group phenotypes along with demographic data of the patients were recorded. The observed proportions of ‘A’ , ‘B’, ‘AB’, ‘O’, ‘Rh’, and ‘Kell’ blood groups in COVID-19 patients were compared against the expected proportions (the null hypothesis) of the general population using Pearson’s chi-squared test and partition analysis.Results: There were significant differences between observed and expected frequency for the ABO and Kell blood phenotypes. Further partition analysis of ABO phenotypes showed that the group ‘A’ phenotypes were more susceptible to COVID-19. The Kell negatives were also more susceptible. The blood groups ‘AB’, ‘B’, ‘O’, and ‘Rh’ showed no significant difference for susceptibility to COVID-19.Conclusion: The study shows a relationship between ABO, Rh, and Kell blood groups and COVID-19 susceptibility. The application of these relationships in clinics should be explored in future studies.","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86697921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}